|
Fernández de Palencia Espinosa MA, Díaz Carrasco MS, Fuster Soler JL, Ruíz Merino G, De la Rubia Nieto MA, Espuny Miró A. Pharmacoepidemiological study of drug-drug interactions in onco-hematological pediatric patients. Int J Clin Pharm. 2014 Dec;36(6):1160-9. doi: 10.1007/s11096-014-0011-1. PubMed PMID: 25204258.
AÑO: 2014; IF: 2.305
|
25204258
|
Olmos-Jiménez R, Díaz-Carrasco MS, Galera-Miñarro A, Pascual-Gazquez JF, Espuny-Miró A. Evaluation of standardized triple intrathecal therapy toxicity in oncohematological pediatric patients. Int J Clin Pharm. 2017 Feb;39(1):126-132. doi: 10.1007/s11096-016-0408-0. Epub 2016 Dec 8. PubMed PMID: 27933487.
AÑO: 2017; IF: 2.305
|
|
Fernández de Palencia Espinosa MÁ, Díaz Carrasco MS, Alonso Romero JL, de la Rubia Nieto A, Espuny Miró A. Potential drug-drug interactions in oncological adult inpatients at a Spanish hospital: epidemiology and risk factors. Int J Clin Pharm. 2015 Dec;37(6):1021-7. doi: 10.1007/s11096-015-0195-z. Epub 2015 Sep 21. PubMed PMID: 26391788.
AÑO: 2015; IF: 2.305
|
|
Olmos-Jiménez R, Espuny-Miró A, Díaz-Carrasco MS, Fernández-Varón E, Valderrey-Pulido M, Cárceles-Rodríguez C. Stability of four standardized preparations of methotrexate, cytarabine, and hydrocortisone for intrathecal use. J Oncol Pharm Pract. 2016 Oct;22(5):659-65. doi: 10.1177/1078155215600905. Epub 2015 Aug 12. PubMed PMID: 26271105.
AÑO: 2016; IF: 1.416
|
|
Diaz-Carrasco MS, Gonzalez-Haba E, Garcia-Soler JI, Espuny-Miro A. Predictive biomarkers of response to immune checkpoint inhibitors. Farm Hosp. 2020 Jul 1;44(4):141-148. doi: 10.7399/fh.11328. PubMed PMID: 32646345.
AÑO: 2020
|